LivaNova's Vagus Nerve Stimulation Therapy device has been granted expanded MRI labeling by the FDA. The approval allows patients using the minimally invasive device to have an appointment at any MRI center in the US and have access to over 90% of routine scans performed on patients with epilepsy.
FDA expands MRI labeling for LivaNova's VNS Therapy device
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.